Marker for determination of sensitivity to anti-cancer agent

Details Marker for determination of sensitivity to anti-cancer agent Marker for determination of sensitivity to anti-cancer agent

G - Physics

01

N

G01N 33/68 (2006.01) A61K 31/4745 (2006.01) A61K 45/00 (2006.01) A61P 35/00 (2006.01) G01N 27/447 (2006.01) G01N 27/62 (2006.01) G01N 33/15 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2712966

Provided are a marker for determining sensitivity to an anticancer agent capable of distinguishing a therapeutic response of an individual patient and a novel means for a cancer therapy using the marker. The marker for determining sensitivity to an anticancer agent contains a substance in a metabolic pathway in which L-phenylalanine and/or N,N-dimethyl glycine are/is involved.

L'invention concerne un marqueur destiné à être utilisé dans le cadre de la détermination de la sensibilité à un agent anticancéreux qui peut déterminer la réponse thérapeutique chez des patients individuels. L'invention concerne également un nouveau moyen de traitement du cancer utilisant le marqueur. L'invention concerne en particulier un marqueur destiné à être utilisé dans le cadre de la détermination de la sensibilité à un agent anticancéreux qui comporte une substance impliquée dans le système métabolique associé à la L-phénylalanine et/ou à la N,N-diméthylglycine.

Affiliated with

Also associated with

Rating

Marker for determination of sensitivity to anti-cancer agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Marker for determination of sensitivity to anti-cancer agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Marker for determination of sensitivity to anti-cancer agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1970892